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A B S T R A C T   
Objective: The goal of this study was to analyze how depression associated with Parkinson’s disease (PD) affected 
gait variability in these patients using a dual-task paradigm. Additionally, the dependency of the executive 
functions and the impact of depression on gait variability were analyzed. 
Patients and Methods: Three subject groups were included: patients with PD, but no depression (PD-NonDep; 14 
patients), patients with both PD and depression (PD-Dep; 16 patients) and healthy controls (HC; 15 subjects). 
Gait was recorded using the wireless sensors. The participants walked under four conditions: single-task, motor 
dual- task, cognitive dual-task, and combined dual-task. Variability of stride length, stride duration, and swing 
time was calculated and analyzed using the statistical methods. 
Results: Variability of stride duration and stride length were not significantly different between PD-Dep and PD- 
NonDep patients. The linear mixed model showed that swing time variability was statistically significantly higher 
in PD-Dep patients compared to controls (p = 0.001). Hamilton Disease Rating Scale scores were significantly 
correlated with the swing time variability (p = 0.01). Variability of all three parameters of gait was significantly 
higher while performing combined or cognitive task and this effect was more pronounced in PD-Dep group of 
patients. 
Conclusions: Depression in PD was associated with swing time variability, and this effect was more prominent 
while performing a dual-task. 
Significance: Diagnosing and treating depression might be important for gait improvement and fall reduction in 
PD patients.   
1. Introduction 
Gait disturbance is one of the particularly incapacitating signs of 
Parkinson’s disease (PD). It is characterized by slowness, variability, and 
postural instability, related to impaired spinal and supraspinal loco-
motor networks (premotor cortical, motor cortical, basal ganglia, cere-
bellar, and brain stem structures). Peterson and Horak suggested that 
slow gait in PD might be related to a dysfunction of the basal ganglia- 
thalamocortical loop, while gait variability appeared when a shift from 
automatic to voluntary control of walking occurred [1]. Gait has been 
increasingly understood as a complex “higher-order” form of motor 
behavior, with prominent influences of mental processes (executive 
function, attention, a judgement of external/internal cues) [2]. Such 
impact is particularly evident under the dual-task (DT) conditions, 
which changes gait parameters, including stride-to-stride variability, 
both in healthy individuals and in PD patients [2–5]. 
Depression is a frequent and significant non-motor symptom of PD, 
with a prevalence of approximately 35 % [6]. It has a modulatory effect 
on cognitive functions and possibly a shared pathophysiological basis 
with disturbances in the executive functions [7]. It has been demon-
strated that unipolar depression by itself also influenced gait parame-
ters, primarily speed and time spent with both feet on the ground [8,9]. 
Depression is an independent predictor of gait speed under single and 
dual-task (DT) conditions in mild to moderately severe PD [5]. 
Keeping in mind the interplay among cognition, gait, and depression, 
as well as the results of studies demonstrating the influence of 
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depression on gait parameters, we wanted to investigate whether 
depression associated with PD affected gait variability in these patients. 
We have hypothesized that: 1) PD patients with major depression (PD- 
Dep) had more expressed gait variability compared to PD patients 
without depression (PD-NonDep), measuring these possible changes by 
using DT paradigm; and 2) the impact of depression on gait variability in 
PD patients might be, at least partially, dependent on executive 
functions. 
2. Materials and methods 
2.1. Subjects 
The study included 30 consecutive, non-demented in-patients with 
PD, diagnosed by a specialist for movement disorders (ND, MS, or IP) 
according to the UK PD Society Brain Bank criteria [10], at the 
Neurology Clinic, Clinical Center of Serbia, Belgrade. 
PD-NonDep and PD-Dep patients were included, while those with 
dysthymia were excluded from the study. The initial version of the 
Unified Parkinson’s Disease Rating Scale (UPDRS) score was used to 
assess parkinsonian signs [11]. 
All patients were interviewed by a psychiatrist (MK) to diagnose 
major depression (MD). The Structured Clinical Interview for DSM-V 
Axis I Disorders (SCID-1) was used as a diagnostic exam to determine 
DSM-V Axis I disorders [12]. Furthermore, all patients were assessed 
with the Hamilton Depression Rating Scale (HDRS) [13]. The Frontal 
Assessment Battery (FAB) [14], Addenbrooke’s Cognitive 
Examination-Revised scale (ACE-R) (total score) [15], Digit Span 
Backward test [16] and Stroop Color and Word test (Stroop interference 
score) [17] were used to evaluate executive functions. Tinetti Balance 
Score (TBS) was also assessed for all patients. Cognitive functions were 
tested using Mini-Mental State Examination scale (MMSE) [18]. Levo-
dopa equivalent dose (LED) was 875.7 ± 485.3 mg. 
Exclusion criteria were: 1) significant memory impairment and 
MMSE<26 or patients who fulfilled criteria for the diagnosis of de-
mentia; 2) independent gait without aids was not possible; 3) additional 
vascular, rheumatoid, and psychiatric comorbidities that might 
contribute to gait difficulties; and 4) neuroleptic treatment. 
The control group (HC) consisted of 15 healthy, gender- and age- 
matched subjects recruited among caregivers and healthy staff mem-
bers at the Neurology Clinic. 
The study was performed in accordance with the ethical standards of 
the Declaration of Helsinki and approved by the Ethical Committee of 
the School of Medicine, University of Belgrade. All the participants gave 
written informed consent before entering the study. 
2.2. Experiment 
The participants were asked to perform a walking task under four 
different conditions (no instruction was given to prioritize one task over 
other in DT paradigm) [19]:  
1) Single-task – walking along a straight path at their usual rhythm;  
2) Motor DT – same as (1) but a participant also carried a glass of water, 
trying not to spill it;  
3) Cognitive DT – same as (1) but a participant in parallel performed 
mathematical task - serial subtractions of “7” from “100”. Sub-
tractions were conducted loudly, and examiners took care that par-
ticipants provided correct answers.  
4) Combined DT – walking the same path while carrying a glass of water 
and performing the described mathematical task. 
The order of testing was randomized using a simple PC program. 
Four walking sequences per one walking condition were recorded for all 
subjects, with 5 min of rest between two consecutive trials and different 
walking conditions. All participants were walking using their shoes. All 
the measurements and testing were performed in the ON state. 
The study was performed in a 15-meter long and 3- meter wide 
hallway. This setup provided participants space and time to walk at a 
natural pace steadily. 
2.2.1. Instrumentation 
We used the previously described custom-made wireless sensor sys-
tem (SENSY) that includes two inertial measurement units (IMUs) and 
two shoe insoles with force sensing resistors (FSR) [20]. Each shoe insole 
has three FSR sensors positioned below the area of the 2nd and 4th 
metatarsal/phalanges proximal bones and calcaneus bone, respectively. 
Shoe insoles were provided in the corresponding size for each subject. 
IMUs comprise 3D accelerometers and 3D gyroscope sensors. During the 
measurement process, the shoe insoles were positioned in the subjects’ 
shoe, whereas IMUs were placed laterally on each foot. 
2.2.2. Gait assessment 
The recorded signals were processed and analyzed by custom-made 
software. The walking sequences were divided into individual walking 
cycles (i.e., strides) using the recorded FSR signals [21]. The first and 
last two strides were excluded from further analysis, since initiation and 
termination of the walking may result in modified gait patterns. The 
selected strides were described with the following parameters: 1) stride 
length expressed in meters (m); 2) stride duration expressed in seconds 
(s); and 3) swing phase duration expressed in seconds (s). These pa-
rameters were calculated using the FSR and IMU data, as previously 
described [22]. 
In order to describe gait intra-variability, a relative change of the 
introduced parameters was calculated as the difference between 
parameter values of two consecutive strides divided by the parameter 
value of the previous stride, expressed as a percentage. The relative 
change of each of the parameters was described with mean value and 
standard deviation, calculated for each walking sequence and task 
separately. 
2.3. Statistical analysis 
Continuous variables corresponding to the clinical and gait data 
were compared between PD-NonDep and PD-Dep groups according to 
their mean values, using a parametric t-test for two independent samples 
or Mann Whitney non-parametric test. Demographic data were 
compared using the parametric one-way analysis of variance (ANOVA). 
The Kolmogorov-Smirnov test was applied to assess the distribution 
normality of investigated demographic, clinical, and gait parameters. 
A linear mixed model was used as a method for analyzing the rela-
tionship between potential predictors and dependent variables: the 
relative change of stride duration, the relative change of stride length, 
and the relative change of swing time. In this paper, both univariate and 
multivariate models were considered. Group (PD-Dep, PD-NonDep, and 
HC as reference category), Task (Single-task as the reference category, 
Motor DT, Cognitive DT, Combined DT), Task repetition, Age, HDRS, 
FAB, and TBS were used as predictors in the univariate models. In 
contrast, for the multivariate models, only the predictors showing sta-
tistical significance were considered. Statistically significant differences 
were found for values p < 0.05. Statistical analysis was performed in 
SPSS v25.0 (IBM, Armonk, NY, USA). 
3. Results 
3.1. Criteria for major depression 
Criteria for MD were met by 16 patients, out of which seven were on 
selective serotonin reuptake inhibitors, two on amitriptyline, two on 
venlafaxine, and 5 of them on mianserin therapy. All patients with the 
diagnosis of MD were in a depressive episode during the examination. In 
the PD-NonDep group, five patients were on SSRIs, although they did 
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not meet the criteria for MD. 
3.2. Comparison of clinical features of PD-NonDep and PD-Dep groups 
By considering demographic and clinical characteristics of patients 
(Table 1), there were no differences in the duration of PD, age between 
the tested groups, and the motor parts of the UPDRS scores between the 
PD- Dep and PD-NonDep groups, although the total UPDRS score was 
significantly higher for patients with depression. The HDRS and TBS 
scores were significantly different between the patient groups, whereas 
the FAB scores were not different between PD-Dep and PD- NonDep 
patients (Table 1). Furthermore, ACE-R, Digit Span Backwards, and 
Stroop interference scores were not significantly different between PD- 
Dep and PD- NonDep groups (Table 1). 
In order to examine if cognitive capacity influenced calculation 
during the DT, the sub-score for calculation task was also analyzed while 
performing the MMSE test. It was shown that most patients had 4 or 5 
points on that task. Only one patient from the PD-Dep group scored with 
3 points on the calculation task. 
3.3. Gait parameters 
In this study, 9,266 strides in total were included in the analysis: 
3,295 from PD-NonDep patients (773 for the single-task, 825 for motor 
DT, 832 for cognitive DT, 865 for combined DT), 3,792 from PD-Dep 
patients (870 for the single-task, 883 for motor DT, 973 for cognitive 
DT, 1,066 for combined DT), and 2,179 from HC subjects (535 for the 
single-task, 549 for motor DT, 544 for cognitive DT, 551 for combined 
DT). PD-NonDep and PD-Dep patients walked with an average gait speed 
of 0.76 m/s and 0.81 m/s, respectively, whereas the average gait speed 
was 1.27 m/s for the HC group. Table 2 presents the results for the 
relative change of the introduced gait parameters: stride duration, stride 
length, and swing time. The results are presented for each group, each 
task, and each task repetition separately. 
3.4. Comparison of gait parameters using linear mixed models 
The univariate linear mixed model analysis showed that variability 
of stride length was significantly higher in PD- NonDep patients 
(p = 0.022) and PD-Dep patients (p = 0.003) compared to controls. 
Similar results were obtained for comparison with patients with higher 
HDRS scores (p = 0.044), patients with lower FAB and TBS scores 
(p = 0.009 and p < 0.001, respectively), and while performing cognitive 
and combined DT (p < 0.001 and p < 0.001, respectively) compared to 
the single-task. The variability of stride length was not significantly 
different between PD-Dep and PD-NonDep patients. The multivariate 
linear mixed model with stride length as the dependent variable showed 
that patients performing cognitive and combined DT (p < 0.001 and 
p < 0.001, respectively), and patients with lower TBS (p = 0.016) had 
higher variability of gait (Table 3). 
Similarly, the univariate linear mixed model analysis showed that 
variability of stride duration was significantly higher in PD-NonDep 
(p = 0.002) and PD-Dep (p = 0.001) compared to the control group. 
The stride duration variability was not significantly different between 
PD-Dep and PD-NonDep patients. A multivariate linear mixed model 
with stride duration as the dependent variable showed that variability 
was higher while performing combined and cognitive DT. Stride dura-
tion variability is higher in subjects with a lower TBS score (p < 0.001). 
Linear mixed model, univariate analysis, showed that swing time 
variability was statistically significantly higher in PD-Dep patients 
compared to controls (p = 0.001) and also was higher compared to PD- 
NonDep patients, but this difference was on the boundary of statistical 
significance (p = 0.063). Variability of swing time was significantly 
higher in patients while performing cognitive and combined tasks 
(p < 0.001 and p < 0.001, respectively) compared to the single-task, and 
it was significantly lower for task repetition (p = 0.038). Patients with 
higher swing time variability had significantly higher HDRS scores 
(p = 0.01) (Fig. 1) and had significantly lower TBS (p = 0.005). A 
multivariate linear mixed model with swing time as dependent variable 
showed that PD-Dep patients had significantly higher variability of gait 
compared to controls (p = 0.03), and while performing cognitive and 
combined tasks (p < 0.001 and p < 0.001, respectively) compared to the 
single-task but was significantly lower for task repetition (p = 0.038) 
(Table 4). 
The linear mixed models with the variability of stride duration, stride 
length and swing time as dependent variables within groups showed that 
the effect of DT cost, or increase in variability during the performance of 
cognitive and combined DT, was higher in the PD-Dep compared to the 
PD-NonDep patient group (Table 5). 
4. Discussion 
Our study showed that the variability of gait is associated with 
depression in PD patients, especially swing time variability, which is 
possibly one of the most sensitive gait parameters. We also showed that 
the effect of depression on the variability of gait parameters is more 
prominent while performing DT. Swing time variability significantly 
correlated with the depression score, and there was also a difference in 
swing time variability between the PD-Dep and PD-NonDep group of 
patients that was close to the level of statistical significance. 
Depression is frequently associated with PD, affecting approximately 
35 % of patients, and strongly influencing motor and cognitive domains 
of the disease, as well as health-related quality of life [23]. The mech-
anisms of depression in PD are complex and traditionally include the 
participation of dopaminergic, serotonergic, and noradrenergic systems 
[24]. It has also been found that depressive symptoms in PD were 
correlated with central cholinergic hypofunction, which has also been 
identified as an independent risk factor for dementia in PD [25], and 
linked with gait disorders and postural instability in PD [26]. Also, 
depression contributed to the variability of stride duration in PD pa-
tients, both in ON and OFF time [27]. Hausdorf et al. [28] demonstrated 
that MD and bipolar disorders contributed to significantly higher vari-
ability of swing time, but not to the stride length and stride duration, 
when compared to controls, suggesting that swing time could be a 
particularly sensitive marker of subtle changes of the neuronal control of 
gait or to an impact of depression. Patients with mild PD also had greater 
swing time variability in comparison to stride duration [29], indicating 
that in the early course of PD, under conditions of small variability, 
swing time might be the first parameter to be disrupted in terms of a gait 
irregularity. In subjects older than 75 years who did not meet criteria for 
Table 1 
Demographic and clinical characteristics (mean ± SDs) for three subject groups, 
together with p-values describing the level of statistically significant differences 
between the PD-NonDep and PD-Dep groups. ACE-R: Addenbrook’s Cognitive 
Examination-Revised Scale; Dep: Depression; FAB: Frontal Assessment Battery; 
HC: Healthy controls; HDRS: Hamilton Depression Rating Scale; PD: Parkinson’s 
disease; TBS: Tinetti Balance Score; UPDRS: Unified Parkinson’s Disease Rating 
Scale.  
Group PD-NonDep 
(n = 14) 
PD-Dep 
(n = 16) 
HC 
(n = 15) 
p 
values 
Age (years) 65.9 ± 7.9 63.9 ± 6.9 62.5 ± 6.9 0.472 
Duration of the 
disease (years) 
8.3 ± 7.6 9.6 ± 4.2 / 0.588 
UPRDS part III 39.6 ± 15.2 43.7 ± 16.6 / 0.496 
HDRS 6.9 ± 4.1 19.7 ± 4.6 / 0.000* 
FAB 14.6 ± 3.2 14.1 ± 2.8 / 0.610 
TBS 22.5 ± 6.12 17.8 ± 5.15 / 0.010 
ACE-R 86.8 ± 8.8 84.7 ± 8.4 / 0.512 
Digit Span 
Backwards 
5.4 ± 1.6 4.7 ± 2.2 / 0.434 
Stroop interference 
score 
25.6 ± 17.5 25.3 ± 12.2 / 0.956  
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Table 2 
Mean values and SDs of relative changes of the gait parameters: stride duration, stride length, and swing time. The values are presented separately for different subject 
groups, tasks, and task repetitions. Dep: Depression; DT: Dual-task; HC: Healthy controls; PD: Parkinson’s disease.  
Task Group 
Stride duration [%] Stride length [%] Swing time [%] 
Task repetition Task repetition Task repetition 
1 2 3 4 1 2 3 4 1 2 3 4 
Single-task 
PD-Dep 2.6±2.3 2.8±2.7 2.2±1.8 2.3±2.2 5.7±4.5 5.4±4.3 5.6±4.8 5.6±4.8 14.3±12.9 16.2±15.1 16.3±13.9 15.9±14.8 
PD-NonDep 3.1±3.4 2.4±2.7 2.7±3.1 2.5±2.9 6.3±6.1 6.1±9.9 6.6±6.8 5.7±5.9 9.8±9.2 10.1 ± 9.5 10.4±9.3 9.2±8.4 
HC 1.5±1.4 1.2±1.2 1.2±1.1 1.2±1.0 3.8±3.1 3.9±2.8 3.8±2.9 4.0±2.8 6.9±6.0 7.2±7.3 6.2±5.6 7.2±6.2 
Motor DT 
PD-Dep 2.5±2.5 2.4±2.2 2.3±2.2 2.3±2.5 5.4±4.6 5.5±4.2 5.7±5.3 5.5±5.5 15.0±12.4 15.9±12.7 15.4±14.2 13.3±12.6 
PD-NonDep 2.8±3.0 2.4±2.9 2.3±2.0 2.4±3.0 5.6±6.0 5.4±5.4 5.5±4.4 5.8±5.5 11.3±10.9 9.7±11.5 9.4±8.4 10.2±8.5 
HC 1.4±1.3 1.2±1.1 1.3±1.2 1.2±1.2 4.0±3.2 3.5±2.5 4.0±3.2 3.7±2.8 6.4±5.4 6.9±5.8 5.9±5.2 6.6±5.5 
Cognitive DT 
PD-Dep 3.8±3.8 4.0±5.7 4.7±5.5 3.7±3.5 7.9±7.0 7.8±7.9 8.2±8.7 7.4±7.4 17.8±19.5 20.0±18.5 20.8±20.4 19.2±26.3 
PD-NonDep 5.0±17.3 3.0±3.3 3.4±3.9 2.8±2.5 6.4±5.8 6.1±4.7 6.8±6.7 6.4±5.5 11.5±10.6 11.3±10.2 9.7±10.1 10.3±9.3 
HC 2.0±1.9 1.6±1.6 1.3±1.1 1.6±1.6 4.9±3.7 4.7±3.5 4.1±3.3 4.5±3.4 6.4±4.8 6.8±5.2 6.8±5.4 7.2±5.3 
Combined DT 
PD-Dep 3.8±3.5 3.3±3.3 3.8±3.8 3.2±3.1 7.0±7.0 7.9±7.1 8.3±10.7 7.6±7.3 19.1±19.7 20.3±19.4 20.3±20.7 15.6±13.8 
PD-NonDep 3.6±4.8 3.3±4.7 3.7±4.1 3.2±3.2 6.8±7.6 6.0±5.9 5.6±5.8 6.2±5.5 11.8±10.7 11.6±10.9 11.5±10.5 11.5±12.2 
HC 1.7±1.6 1.6±1.4 1.6±1.4 1.6±1.5 4.6±3.6 4.2±3.4 4.1±3.3 4.6±3.3 6.5±5.1 7.0±5.8 7.0±6.1 7.0±5.6  
Table 3 
A linear mixed model with a relative change of stride length as the dependent variable. Dep: Depression; DT: Dual-task; FAB: Frontal Assessment Battery; HC: Healthy 
controls; HDRS: Hamilton Depression Rating Scale; PD: Parkinson’s disease; TBS: Tinetti Balance Score.   
B SE p. B SE p. 
Group       
PD-Dep 2.49 0.78 0.003 0.52 1.01 0.607 
PD-NonDep 1.89 0.80 0.022 0.67 0.87 0.446 
HC Reference Category  Reference Category  
Task       
Single-task Reference Category  Reference Category  
Motor DT − 0.24 0.14 0.084 − 0.24 0.14 0.084 
Cognitive DT 1.04 0.14 <0.001 1.04 0.14 <0.001 
Combined DT 0.88 0.14 <0.001 0.88 0.14 <0.001 
Task repetition − 0.03 0.05 0.525    
Age 0.06 0.05 0.200    
HDRS 0.09 0.04 0.044    
FAB − 0.31 0.11 0.009 − 0.11 0.12 0.366 
TBS − 0.37 0.09 <0.001 − 0.29 0.11 0.016  
Fig. 1. Correlation between the variability of swing time and the HDRS score. HDRS: Hamilton Depression Rating Scale.  
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MD, it has been shown that contrary to stride duration and stride length, 
swing time variability was clearly associated with symptoms of 
depression, even when factors such as vascular comorbidity and cogni-
tive status were taken into account [30]. Moreover, Frenkel-Toledo et al. 
[31] have demonstrated that contrary to stride duration variability, 
swing time variability was independent of gait speed, which implied 
possible different mechanisms for these two gait parameters. Although 
we could not confirm that depression was an independent factor for the 
variability of three gait parameters, probably due to the small number of 
patients, PD-Dep group of patients had significantly higher swing time 
variability compared to control group while this was not shown with 
PD-NonDep patients. HDRS score was not just significantly correlated 
with the swing time variability but it was significantly higher in patients 
with higher stride length variability. 
The motor-cognitive DT paradigm has been used to examine an 
interplay between gait and cognition [32,33], affecting gait variability 
both in healthy subjects and PD patients [3,34], with consequent in-
crease of the risk of falls and worsened daily functioning [4]. Even in 
cognitively normal, older adults, there was a robust association of gait 
speed and gait variability with executive function, attention, and (to a 
lesser extent) memory and visuospatial function, that was more 
emphatic under DT conditions [33,35–38]. Attention and executive 
functions were impaired early in PD and were manifested in an inability 
for adequate separation of cognitive resources required for the simul-
taneous performance of activities during DT [5,39]. Similar to our re-
sults, it has been shown that DT affected the swing time and step length 
variability, as well as double support time in PD, particularly in those 
with mild cognitive impairment when compared to the control group 
[40]. Patients with MD performed the Walking Trial Making Test more 
slowly, with lower gait accuracy and higher DT costs when compared to 
controls [41]. Late-onset depression in subjects without PD has been 
coupled with cognitive disturbances and, in particular, with executive 
dysfunction, probably reflecting shared frontostriatal pathology [42]. 
Results on executive function tests were a predictive factor for higher 
variability of gait parameters when performing DT in older patients with 
MD who were under the risk of falls [41]. Gabel et al. [43] found that 
older patients with MD did not exhibit differences in the variability of 
gait parameters when compared to non-depressive matched subjects, 
either during single- task conditions or during DT performance. How-
ever, results of cognitive testing indicated a link with increased vari-
ability during DT performance only in the group of depressed, but not in 
the group of non-depressed patients. DT significantly increased the 
variability of all three gait parameters in our study, and performing DT 
was an independent factor for variability when using all three parame-
ters as the dependent variable. Besides this, the variability of stride 
length was higher in patients with the higher FAB score but not vari-
ability of swing time, and FAB did not turn out to be an independent 
variable. Also, there was no difference in the FAB, ACE-R, Digit Span 
Backwards and Stroop inference scores between PD-Dep and PD- Non-
Dep patients, which, together with the results for the HDRS score, 
implied that the influence of depression is partially independent of ex-
ecutive functions. Although DT significantly affected the variability of 
all three parameters, this effect was more expressed in the group of 
depressed patients meaning that depression probably influenced gait 
Table 4 
A linear mixed model with relative change of swing time as the dependent variable. Dep: Depression; DT: Dual-task; FAB: Frontal Assessment Battery; HC: Healthy 
controls; HDRS: Hamilton Depression Rating Scale; PD: Parkinson’s disease; TBS: Tinetti Balance Score.   
B SE p. B SE p. 
Group       
PD-Dep 10.14 2.72 0.001 7.99 3.56 0.030 
PD-NonDep 3.70 2.77 0.190 2.51 3.04 0.412 
HC Reference Category  Reference Category  
Task       
Single-task Reference Category  Reference Category  
Motor DT − 0.29 0.26 0.256 − 0.29 0.26 0.256 
Cognitive DT 1.51 0.26 <0.001 1.51 0.26 <0.001 
Combined DT 1.63 0.26 <0.001 1.63 0.26 <0.001 
Task repetition − 0.17 0.08 0.038 − 0.17 0.08 0.038 
Age − 0.21 0.18 0.237    
HDRS 0.41 0.15 0.010    
FAB − 0.45 0.44 0.307    
TBS − 1.01 0.34 0.005 − 0.40 0.43 0.359  
Table 5 
A linear mixed model with a relative change of (a) stride duration, (b) stride length, and (c) swing time as the dependent variables, within PD-Dep and PD-NonDep 
groups. Dep: Depression; DT: Dual-task; PD: Parkinson’s disease.  
Task PD-Dep PD-NonDep 
stride duration B SE p. B SE p. 
Single-task Reference Category  Reference Category  
Motor DT − 0.1 0.15 0.497 − 0.18 0.25 0.474 
Cognitive DT 1.56 0.15 <0.001 0.87 0.25 0.001 
Combined DT 1.06 0.15 <0.001 0.79 0.25 0.002  
stride length 
Single-task Reference Category  Reference Category  
Motor DT − 0.03 0.29 0.905 − 0.63 0.27 0.021 
Cognitive DT 2.24 0.29 <0.001 0.22 0.27 0.424 
Combined DT 2.15 0.29 <0.001 − 0.04 0.27 0.880  
swing time 
Single-task Reference Category  Reference Category  
Motor DT − 0.74 0.60 0.216 0.3 0.44 0.487 
Cognitive DT 3.78 0.60 <0.001 0.84 0.44 0.053 
Combined DT 3.2 0.60 <0.001 1.74 0.44 <0.001  
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parameters, especially in conditions of additional cognitive or combined 
tasks. Nevertheless, it is possible that DT performance detects more 
subtle cognitive decrements than those observed in the used executive 
tests. 
Variability of three gait parameters was more expressed in patients 
who had lower TBS scores, and TBS was an independent predictor for 
swing time variability. Depression represents an independent risk factor 
for falls in older individuals, where several studies have demonstrated a 
connection between depression and postural instability [44]. Previous 
studies have demonstrated that older patients with major depression, 
who are under the risk of falling, have lower scores on executive func-
tion tests, which had predictive significance for gait variability under DT 
conditions compared to base gait [43]. They proposed the hypothesis 
that executive functions contribute to greater problems in walking for 
older individuals with depression compared to those without depres-
sion, but at the same time, no difference was found in gait parameter 
variability under DT conditions compared to base conditions. In our 
study, patients with depression and those without depression had 
significantly different TBS scores, although there was no significant 
difference in executive functions in the FAB test. PD patients also exhibit 
a change in this nucleus [45]. Moreover, observed changes in cholin-
ergic function in patients with PD and depression and demonstrated the 
influence of cholinergic dysfunction on gait and postural control could 
point to a similar pathophysiological origin. Depression is coupled with 
axial motor symptoms in PD and appears more frequently in a form with 
pronounced postural instability and gait disorders [46,47]. A recent 
study has demonstrated that patients with PD and comorbid depression 
exhibit differences in postural control compared to patients without 
depression, wherein the upright position depressive patients exhibit 
greater flexion in the pelvic area, causing leaning forward of the torso 
[48]. In our study, patients with PD and depression had significantly 
lower scores on the TBS, which suggests that depression could addi-
tionally impair balance and contribute to falls. 
The main limitation of our study was a relatively small number of 
patients. However, we performed a detailed clinical and psychological 
evaluation. The diagnosis of MD was based on standardized psychiatric 
instruments, and not just by using depression scales. Furthermore, gait 
was tested using wireless sensors (closer to normal gait conditions than 
testing on a treadmill). 
The clinical implication of the possible influence of depression on 
gait parameters is important, especially the variability of gait since it is 
well known that the variability of gait is one of the main risk factors for 
falls. Our results confirmed that recognizing depression and its treat-
ment could be one of the possible strategies for improving balance and 
gait. In conclusion, we have demonstrated that MD in PD was associated 
with gait variability, particularly during DT conditions, which has been 
previously shown to be a significant predictor of future falls. Therefore, 
strategies for improvement of gait and reduction of fall risks in PD may 
include clinical efforts for early recognition and treatment of depression. 
Future studies should include a greater number of patients, including 
those that meet minor depression criteria, as well as subsyndromal 
depression (patients who experience depression only in OFF periods). It 
would also be interesting to test, on a larger group of patients whether 
there are differences in gait parameters in patients who have diagnosed 
major depression but have emerged from an episode and are taking 
adequate therapy, and to test how the DT paradigm affects patients with 
depression, but without PD. 
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L. Dušek, P. Kaňovský, I. Rektor, T. Pavlík, P. Filip, M. Bareš, Motion and emotion: 
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